These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27542099)

  • 1. Immune cells in repair of the infarcted myocardium.
    Chen B; Frangogiannis NG
    Microcirculation; 2017 Jan; 24(1):. PubMed ID: 27542099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
    Prabhu SD; Frangogiannis NG
    Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.
    Frangogiannis NG
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):185-95. PubMed ID: 24072174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune system and cardiac repair.
    Frangogiannis NG
    Pharmacol Res; 2008 Aug; 58(2):88-111. PubMed ID: 18620057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the inflammatory response in cardiac repair.
    Frangogiannis NG
    Circ Res; 2012 Jan; 110(1):159-73. PubMed ID: 22223212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mechanisms in myocardial infarction.
    Ren G; Dewald O; Frangogiannis NG
    Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):242-56. PubMed ID: 14561159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblasts in myocardial infarction: a role in inflammation and repair.
    Shinde AV; Frangogiannis NG
    J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.
    Hilgendorf I; Frantz S; Frangogiannis NG
    Circ Res; 2024 Jun; 134(12):1718-1751. PubMed ID: 38843294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the chemokines in cardiac repair.
    Cavalera M; Frangogiannis NG
    Curr Pharm Des; 2014; 20(12):1971-9. PubMed ID: 23844733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.
    Saxena A; Shinde AV; Haque Z; Wu YJ; Chen W; Su Y; Frangogiannis NG
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):223-31. PubMed ID: 26542797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in cardiac injury, repair and regeneration.
    Frangogiannis NG
    Curr Opin Cardiol; 2015 May; 30(3):240-5. PubMed ID: 25807226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
    Frangogiannis NG; Ren G; Dewald O; Zymek P; Haudek S; Koerting A; Winkelmann K; Michael LH; Lawler J; Entman ML
    Circulation; 2005 Jun; 111(22):2935-42. PubMed ID: 15927970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of Myocardial Infarction.
    Frangogiannis NG
    Compr Physiol; 2015 Sep; 5(4):1841-75. PubMed ID: 26426469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction.
    Kologrivova I; Shtatolkina M; Suslova T; Ryabov V
    Front Immunol; 2021; 12():664457. PubMed ID: 33868315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.
    Saxena A; Russo I; Frangogiannis NG
    Transl Res; 2016 Jan; 167(1):152-66. PubMed ID: 26241027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts.
    Frangogiannis NG
    Discoveries (Craiova); 2015; 3(1):. PubMed ID: 26273700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines in Myocardial Infarction.
    Chen B; Frangogiannis NG
    J Cardiovasc Transl Res; 2021 Feb; 14(1):35-52. PubMed ID: 32415537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory response in myocardial injury, repair, and remodelling.
    Frangogiannis NG
    Nat Rev Cardiol; 2014 May; 11(5):255-65. PubMed ID: 24663091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting inflammatory pathways in myocardial infarction.
    Christia P; Frangogiannis NG
    Eur J Clin Invest; 2013 Sep; 43(9):986-95. PubMed ID: 23772948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium.
    Saxena A; Chen W; Su Y; Rai V; Uche OU; Li N; Frangogiannis NG
    J Immunol; 2013 Nov; 191(9):4838-48. PubMed ID: 24078695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.